NCT03087136View on ClinicalTrials.gov

A Multicenter Observational Study to Evaluate Pediatric Multiple Sclerosis in Brazil

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Multiple Sclerosis
Interventions
DIAGNOSTIC_TEST

anti-aquaporin-4 antibody

Serum anti-aquaporin-4 antibody

DIAGNOSTIC_TEST

anti-myelin oligodendrocyte glycoprotein

Serum anti-myelin oligodendrocyte glycoprotein

Trial Locations (8)

9061000

Pontifical Catholic University of Rio Grande do Sul, Porto Alegre

22290255

Universidade Federal do Estado do Rio de Janeiro, Rio de Janeiro

38405320

Universidade Federal de Uberlândia, Uberlândia

50110900

Hospital da Restauração de Recife, Recife

65470000

Hospital das Clinicas da Faculdade de Medicina de Ribeirão Preto / Universidade de São Paulo, Ribeirão Preto

81210310

Instituto de Neurologia de Curitiba, Curitiba

90020090

Santa Casa de Misericordia de Porto Alegre, Porto Alegre

05403010

Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo

All Listed Sponsors
collaborator

Teva Pharmaceuticals USA

INDUSTRY

lead

Pontificia Universidade Católica do Rio Grande do Sul

OTHER

NCT03087136 - A Multicenter Observational Study to Evaluate Pediatric Multiple Sclerosis in Brazil | Biotech Hunter | Biotech Hunter